FREE LIVE WEBINARS FOR MEMBERS & NON MEMBERS

Each month, the NATA scientific committee organises a one-hour interactive session led by top experts, featuring a hot topic related to clinical practice.

Registered participants can submit questions during the session.

UPCOMING WEBINAR

Clotting bleeding and pregnancy: pay attention!

Date: TUESDAY 25 MARCH

Time: 18:00 – 19:00 CET

Clotting bleeding and pregnancy: pay attention!

Speakers:

Beverley Hunt, London, UK

VTE in pregnancy: what a mess we are in! What do we do now?

Sue Pavord, Oxford, UK

Anaemia in pregnancy – ironing out the problem

Viscoelastic testing: the worst way to use them

Thorsten Haas

Viscoelastic testing (VET) is a real-time, whole blood, point-of-care measurement to assess clot formation, strength, and clot lysis. The available VET assays help to identify the contribution and potential disruptions of platelets, fibrinogen, and coagulation factors to clotting. 

This talk is intended to give a brief overview of VET tools and will give a comprehensive update of current literature. A special focus will be on the rational use of VET to guide bleeding management in the clinical practice. 

Learning objectives:

  • To describe how the test works, what it measures, and to describe the benefits and limitations. 
  • To understand how to use the information from the VET test to guide bleeding management.
  • To give examples of a reasonable approach how to use VET.

 

LEARNING OBJECTIVES

  • The limitations of traditional biomarkers like serum ferritin and transferrin saturation in inflammatory states.
  • How CRP can be used in the interpretation of ID biomarkers.
  • An evidence based approach to improve diagnostic accuracy in hospitalised and unwell patients.
  • The role of serum ferritin as the most reliable parameter and the limited utility of reticulocyte hemoglobin in diagnosis of ID.


Iron deficiency is a highly prevalent condition with effective treatment options, but various diagnostic pitfalls prevent many patients from receiving therapy. Concurrent inflammation is a key cause of underdiagnosis and requires a nuanced clinical approach. We will present findings from a cross-sectional study conducted at a tertiary academic hospital in Cape Town, South Africa. The study evaluated optimal biomarker thresholds for diagnosing ID, using bone marrow (BM) iron stores as the gold standard and C-reactive protein (CRP) as an inflammatory marker.

 

PAST webinars - WATCH THE REPLAYS

Subscribe to our newsletter

Play Video
Play Video

PREOPERATIVE AND MASSIVE BLEEDING GUIDELINES: WHAT's NEW

Consent Management Platform by Real Cookie Banner